An article Scale-Up Synthesis of IID572: A New beta-Lactamase Inhibitor WOS:000551555800004 published article about ACIDS in [Furegati, Markus; Nocito, Sandro; Schuetz, Heiner; Koch, Guido] Novartis Inst BioMed Res, Synth & Technol Grp, CH-4057 Basel, Switzerland; [Reck, Folkert; Casarez, Anthony; Simmons, Robert] Novartis Inst BioMed Res, Emeryville, CA 94608 USA in 2020.0, Cited 19.0. Quality Control of 4-Nitrobenzoic acid. The Name is 4-Nitrobenzoic acid. Through research, I have a further understanding and discovery of 62-23-7
The new potentially best-in-class beta-lactamase inhibitor IID572 was discovered by a late-stage functionalization approach. An alternative synthesis was developed to satisfy the short-term material need for toxicological studies in animals. The new synthetic strategy was built on two key features, an intramolecular azomethine ylide [3 + 2] cycloaddition that allowed the efficient formation of molecular complexity from readily available starting materials and an enzymatic resolution that resulted in high optical purity of a key intermediate.
Quality Control of 4-Nitrobenzoic acid. Welcome to talk about 62-23-7, If you have any questions, you can contact Furegati, M; Nocito, S; Reck, F; Casarez, A; Simmons, R; Schuetz, H; Koch, G or send Email.
Reference:
Phthalazine – Wikipedia,
,Phthalazine | C8H6N2 – PubChem